Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11390642 Compositions comprising reversibly modified oligonucleotides and uses thereof

Patent 11390642 was granted and assigned to Dicerna Pharmaceuticals on July, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Dicerna Pharmaceuticals

Current Assignee

Dicerna Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

113906420

Patent Inventor Names

Venkata Krishnamurthy0

Weimin Wang0

Date of Patent

July 19, 2022

Patent Application Number

163259790

Date Filed

August 23, 2017

Patent Citations

‌

US Patent 10307434 Nucleic acid prodrugs and methods of use thereof

Patent Primary Examiner

CPC Code

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11390642 Compositions comprising reversibly modified oligonucleotides and uses thereof

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API